Processing

Please wait...

Settings

Settings

Goto Application

1. CN101171256 - Fused thiazole derivatives having affinity for the histamine h3 receptor

Office China
Application Number 200680015514.8
Application Date 10.03.2006
Publication Number 101171256
Publication Date 30.04.2008
Publication Kind A
IPC
C07D 513/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
513Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/, C07D477/232
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
A61K 31/55
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
55having seven-membered rings, e.g. azelastine, pentylenetetrazole
A61P 25/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
Applicants Glaxo Group Ltd.
葛兰素集团有限公司
Inventors Bailey Nicholas
尼古拉斯·贝利
Pickering Paula Louise
葆拉·L·皮克林
Wilson David
戴维·M·威尔逊
Agents zhaoren lin zhangbeng yuan
北京市柳沈律师事务所
北京市柳沈律师事务所
Priority Data 0505205.5 14.03.2005 GB
0525239.0 12.12.2005 GB
Title
(EN) Fused thiazole derivatives having affinity for the histamine h3 receptor
(ZH) 具有组胺H3受体亲和性的稠合噻唑衍生物
Abstract
(EN)
The present invention relates to novel fused thiazole derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.

(ZH)

本发明涉及新的具有药理学活性的稠合噻唑衍生物,它们的制备方法,含有它们的组合物以及它们在治疗神经和精神疾病中的用途。